Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7505030 | Drug and Alcohol Dependence | 2015 | 12 Pages |
Abstract
These data suggest that, in the short term, introduction of an abuse-deterrent formulation of OxyContin® in Australia was associated with a reduction in injection of OxyContin®, with no clear switch to other drugs. Reformulated OxyContin®, in this short follow-up, does not appear to be considered as attractive for tampering.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Louisa Degenhardt, Raimondo Bruno, Robert Ali, Nicholas Lintzeris, Michael Farrell, Briony Larance,